Results 121 to 130 of about 8,316 (203)

Projection du fardeau du cancer au Canada en 2024. [PDF]

CMAJ
Brenner DR, Gillis J, Demers AA, Ellison LF, Billette JM, Zhang SX, Liu JL, Woods RR, Finley C, Fitzgerald N, Saint-Jacques N, Shack L, Turner D, pour le Comité consultatif des statistiques canadiennes sur le cancer.   +13 more
europepmc   +1 more source

Objective Evidence for Mind-body Interventions: Selective Modulation of Meridian-wise Bioelectrical Conductance by Yogic Practices. [PDF]

Ann Afr Med
Jiwane R, Malhotra V, Wakode S, Bhargava N, Keswani J, Javed D, Cidral-Filho FJ, Porter P, Mittal GC.   +8 more
europepmc   +1 more source

A decade of Non-Small Cell Lung Cancer management: threats and opportunities in resource-limited setting. [PDF]

Tunis Med
Mejri N, Haouari AA, Saadi M, Berrazaga Y, Haddeoui S, Ghorbel L, Boussen H, Rachdi H, Hamdi Y.   +8 more
europepmc   +1 more source

Rifampicin for the treatment of a cardiogenic shock related to mavacamten toxicity: the worse and the best of drug interactions from a case report. [PDF]

Eur Heart J Case Rep
Lucas S, Hennart B, de Groote P, Lamblin N, Ridon H, Dupre C, Lionet A, Lemesle G.   +7 more
europepmc   +1 more source

Is pneumonectomy still relevant for non-small cell lung cancer? Long-term overall survival from a 15-year experience. [PDF]

Can J Surg
Hache PL, Galvaing G, Simard S, Couture EJ, Sassi S, Champagne C, Conti M, Gregoire J, Laliberté AS.   +8 more
europepmc   +1 more source

Endobronchial Actinomycosis - The Great Masquerader. [PDF]

Ann Afr Med
Al Shuraiqi M, Pasha SMM, Al Harrasi M, Bennji SM, Ismail B, Osman MA.   +5 more
europepmc   +1 more source

Impact of corticosteroids on the efficacy of first-line pembrolizumab plus chemotherapy in patients with advanced non-small-cell lung cancer. [PDF]

Ther Adv Med Oncol
Roboubi A, Wasielewski E, Bordier S, Turlotte A, Pavaut G, Scherpereel A, Cortot A, Gauvain C.   +7 more
europepmc   +1 more source

Analyse en conditions réelles des effets indésirables des anticorps mobilisateurs de lymphocytes T administrés en oncologie et des conséquences opérationnelles. [PDF]

Can Oncol Nurs J
Fernandes S, Nijjar D, Rahaman L, Farley S, Delawala S.   +4 more
europepmc   +1 more source